In Depth 4 Nov 2025 The biggest biotech funding rounds in October 2025 The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025. November 4, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by VALIDOGEN 4 Nov 2025 Rethinking protein production: Why Pichia pastoris is gaining ground in biotech Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems. November 4, 2025 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2025 AAVantgarde closes $141 million series B round to tackle inherited eye diseases Today AAvantgarde closes a $141 million series B round to advance its inherited eye diseases pipeline; find out more about its approach! November 3, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 31 Oct 2025 Spooky science: lab-grown breakthroughs or nightmares? From growing mini-organs to reviving the dodo and gene-editing embryos, boundaries between sci-fi and today’s advances are dissolving fast. October 31, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 31 Oct 2025How AI Is revolutionizing synthetic biology and biomanufacturing Today, with Héctor García Martín, scientist Lawrence Berkeley National Laboratory we’ll dive into why biology has proven so hard to engineer, how AI and robotics are changing that. October 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 29 Oct 2025 Parkinson’s disease: biotech’s pursuit for more therapies Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store? October 29, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Oct 2025 Eight AI deals in 2025: Discover where industry leaders are betting big Artificial intelligence (AI) is rapidly transforming the biotechnology landscape, and as it does, we are seeing more and more strategic collaborations and partnerships focused on the technology. These partnerships make use of AI to analyze complex biological data, speed up drug discovery, and improve the design of clinical trials. By combining AI’s data-crunching capabilities with […] October 28, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Oct 2025 The 11 most advanced microbiome players aiming for the gut Take a look at 11 of the top biotech companies working on the development of gut microbiome therapies to treat a range of diseases. October 28, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2025 The ESMO 2025 digest: Is oncology in good shape? The 2025 edition of the European Society for Medical Oncology (ESMO) was held this week in Berlin, delve into its key highlights. October 24, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 24 Oct 2025Pichia pastoris: the microbial protein expression platform you’re probably underestimating Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris. October 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 Novartis has been on a shopping spree of late. Find out about the pharma giant’s latest deals of 2025. October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing With Eli Lilly’s recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents. October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email